Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers

OBJECTIVE: The goal of the current investigation was to examine a cohort of symptomatic and asymptomatic LRRK2 mutation carriers, in order to address whether the reported alterations in amyloid β (Aβ) and tau species in the CSF of patients with sporadic Parkinson disease (PD) are a part of PD pathog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aasly, J.O., Shi, M., Sossi, V., Stewart, T., Johansen, K.K., Wszolek, Z.K., Uitti, R.J., Hasegawa, K., Yokoyama, T., Zabetian, C.P., Kim, H.M., Leverenz, J.B., Ginghina, C., Armaly, J., Edwards, K.L., Snapinn, K.W., Stoessl, A.J., Zhang, J.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2012
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466497/
https://ncbi.nlm.nih.gov/pubmed/22170881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31823ed101
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars